One area Moderna is now focusing on is mRNA vaccines against respiratory viruses such as influenza and RSV, which cause serious infection and have a high economic burden. In the US alone ...

Sanofi and Translate Bio have started a first clinical trial of an mRNA-based seasonal flu vaccine, adding to the COVID-19 shot already in testing as part of their three-year old collaboration.

The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that the World Health Organization (WHO ...

This video explains the science behind mRNA vaccines and how they could be used to tackle other diseases like HIV, the flu, and even cancer. mRNA vaccines helped dampen the COVID-19 pandemic ...

Scientists say they have made a breakthrough designing a vaccine against all 20 known types of flu. It uses the same messenger-ribonucleic-acid (mRNA) technology as successful Covid vaccines.

Competitors Pfizer and BioNTech are testing a similar two-in-one mRNA vaccine against flu and Covid. Scientists hope mRNA vaccines will be faster to make and update than the current ones used ...

Moderna (MRNA) expects to release early-stage data for its mRNA-based bird flu shot within the next few weeks. The contract comes as the U.S. reports bird flu cases attributed to the H5N1 strain ...

Moderna’s pioneering COVID shot turned the company ... show the versatility of mRNA technology to more effectively treat and ...

Pfizer and Moderna are reportedly developing a mRNA bird flu vaccine, which is the same technology used in Covid-19 vaccines. A teenager in British Columbia is in critical condition after ...

COVID-19 vaccines are effective at preventing severe disease, hospitalization, and death from COVID. Currently, there are two types of COVID-19 vaccines for use in the United States: mRNA vaccines and ...